1. Topical ophthalmic aqueous multidose formulation comprising: increases the viscosity of the system consisting of: i) increasing the viscosity of the dissipating agent which exhibits an increased viscosity when the composition is administered to the ocular surface of the human eye, but it dissipates and gradually loses viscosity subsequently and ii) sensitive to ions increases the viscosity agent that exhibits a lower viscosity when the composition is administered to the ocular surface of the human eye, but shows an increased viscosity after administration to the ocular surface of the eye ivody.2. Ophthalmic composition according to Claim. 1 further comprising a therapeutic agent.3. Ophthalmic composition according to Claim. 1, wherein the ion-sensitive agent is selected from the group consisting of gellan gum, carrageenan, alginic acid and carboxyvinyl polimer.4. Ophthalmic composition according to claim. 3, wherein the dissipating agent is a viscosity-increasing polymer selected from the group consisting of carboxyvinyl polymer, HPMC, HEC, CMC, PVP, polyvinyl alcohol or any kombinatsii.5. Ophthalmic composition according to any one of the preceding claims. 1-4, wherein the viscosity-increasing agentobespechivaet dissipated in the composition is additional viscosity which is at least 10 cps, but not more than 100 sP.6. Ophthalmic composition according to any one of the preceding claims. 1-4, wherein the concentration of the viscosity enhancing agent is dissipated in the composition is at least about 0.10 wt. / Vol.% But not more than about 2.5 wt. / Vol.%. 7.1. Топическая офтальмологическая многодозовая водная композиция, содержащая:увеличивающую вязкость систему, состоящую из:i) диссипирующего увеличивающего вязкость агента, который демонстрирует увеличенную вязкость при введении композиции на окулярную поверхность человеческого глаза, но при этом диссипирует и постепенно теряет вязкость впоследствии иii) чувствительный к ионам увеличивающий вязкость агент, кото
